Live Breaking News & Updates on Likejohnson Johnson Trade

For most companies, making a product for which theres guaranteed demand Around The World sounds too good to be true, but a successful covid 19 vaccine promises to be just that. One vaccine shot, or a couple as your first booster, is not going to provide lifetime immunity to the virus, so the manufacturers are set to reap the profits for years to come. Drug maker pfizer reports its earnings later today, the question is which of the drugs firms are going to come out on top, and how lucrative Will Making Vaccines actually turn out to be . Joining me now is Sunaina Sinha haldea, managing partner, cebile capital. Thank you for being on the program. First of all, pfizer, when it comes to its news today. This will obviously not have in todays earnings, profits it is going to make with this vaccine it has come up with thi ....

Bbc News , The Business Of Making Vcaccines , Around The World , Accellerating Trend , Covid 19 , Drug Maker Pfizer , Will Making Vaccines , Drugs Firms , Vaccine Shot , Sunaina Sinha Haldea , Managing Partner , Cebile Capital , Won T , Revenue Up , Revenue Bump , Long Term , Profit Share , Pfizer Trades , Likejohnson Johnson Trade , Likejohnson Johnson , Growth Stocks , Market Toda , Big Pharma Companies , Don T Stay , Doesn T , Research Efforts ,